Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study.
第一作者:
Michael D,Prados
第一单位:
Department of Neurological Surgery, University of California San Francisco, 400 Parnassus Ave., Room 808, San Francisco, CA 94143-0372, USA. pradosm@neurosurg.ucsf.edu
作者:
主题词
肾上腺皮质激素类(Adrenal Cortex Hormones);成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);曲线下面积(Area Under Curve);脑水肿(Brain Edema);脑肿瘤(Brain Neoplasms);达卡巴嗪(Dacarbazine);剂量效应关系, 药物(Dose-Response Relationship, Drug);女(雌)性(Female);胶质母细胞瘤(Glioblastoma);神经胶质瘤(Glioma);人类(Humans);卡诺夫斯基能力状态(Karnofsky Performance Status);男(雄)性(Male);中年人(Middle Aged);喹唑啉类(Quinazolines)
DOI
10.1007/s00280-007-0556-y
PMID
17694310
发布时间
2018-12-01
- 浏览19
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



